Quest Diagnostics, US74834L1008

Quest Diagnostics stock heads into the open after a 0.4 percent gain

Published on 09/25/2026 at 07:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Quest Diagnostics stock was at USD 236.10 after gaining 0.4 percent, while the S&P 500 slipped 0.02 percent. Barclays maintained a Buy rating with a USD 250 target.

Automatisierter Laboranalysator mit Blutproben-Röhrchen in klinischem Diagnostiklabor
Quest Diagnostics US74834L1008 zeigt automatisierten Laboranalysator mit Blutproben in modernem Diagnostiklabor fotorealistisch dargestellt, Illustration mit AI erstellt.

Quest Diagnostics stock closed at USD 236.10 on the NYSE on September 24, 2026, up 0.4 percent. The shares outperformed the S&P 500, which closed at 7,704.13, down 0.02 percent on the same session.

September 24, 2026 in numbers

Quest Diagnostics Incorporated (ISIN US74834L1008) traded between USD 234.80 and USD 237.45 on the NYSE on September 24, 2026. The closing price was USD 1.34 above the USD 234.76 close cited for the prior Tuesday in a report published by The Globe and Mail.

Barclays maintained a Buy rating and a USD 250 price target in a report released on September 24, 2026, according to The Globe and Mail. The target stood USD 13.90 above the September 24 close.

September 25, 2026 outlook

US trading resumes before the open on September 25, 2026. The S&P 500 finished the prior session at 7,704.13, while the Nasdaq Composite closed at 26,939.37, up 0.01 percent, providing the main broad-market reference for the session ahead.

Disclaimer...

en | US74834L1008 | QUEST DIAGNOSTICS | boerse | 70181716 | bgmi